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Plague is an important zoonotic bacterial disease, and a cause of significant 
mortality in wild rodents and rabbits. In some animals such as prairie dogs, outbreaks 
may kill nearly all of the animals in a colony. Sporadic cases also occur in other wild 
and domesticated mammals, particularly felids. Infections in animals can be 
transmitted to humans, resulting in life-threatening disease. Pneumonic plague, which 
is a particularly deadly form of the disease, is usually fatal if antibiotics are not started 
very soon after the symptoms appear. Bubonic plague, the most common form, is less 
fulminant, but also has a high mortality rate if left untreated. 
At least three major plague pandemics have been seen in human populations. The 
Justinian plague occurred in the Mediterranean region in the 6th century AD and 
caused an estimated 100 million deaths, and the Black Death killed a third of the 
European population beginning in the 14th century. The most recent pandemic, which 
began in China in the late 1800s, spread worldwide and caused an estimated 12 
million fatalities by 1930. The organisms that caused these three pandemics still exist 
in wild animal reservoirs in parts of the world, and occasionally spill over from these 
reservoirs to affect people or other animals. More than a thousand human cases and 
100 to 200 deaths are reported annually to the World Health Organization (WHO), 
and many additional cases are probably not diagnosed. Most outbreaks occur in Asia 
and Africa, but sporadic cases and outbreaks can be seen in any endemic region. 
Plague may reoccur after a long period when the disease seems to disappear; recent 
outbreaks in India, Indonesia and Zambia followed quiescent periods of 30 to 50 
years. An additional concern is that the agent of plague has been identified as a 
potential biological weapon. 
Etiology 
Plague results from infection by Yersinia pestis, a Gram negative bacillus in the 
family Enterobacteriaceae. Only one serotype is recognized. Y. pestis can be divided 
into three biovars: Antiqua, Medievalis, and Orientalis. The Antiqua strains are more 
variable than isolates in the other two biovars. Other classification schemes have also 
been proposed, and some recent analyses classify isolates using genetic markers.  
There are three principal forms of plague, defined mainly by the syndrome in 
humans. Bubonic plague is the most common form, and usually results from the 
inoculation of Y. pestis into the skin. Patients with bubonic plague typically develop a 
swollen and very painful draining lymph node, called a bubo, in addition to other 
clinical signs. Pneumonic plague occurs after the inhalation of bacteria (primary 
pneumonic plague) or after blood–borne spread to the lungs (secondary pneumonic 
plague). The third form, septicemic plague, may occur without obvious involvement 
of the lymph nodes (primary septicemic plague) or as the result of dissemination of 
the other two forms.  
Recent evidence suggests that attenuated strains of Y. pestis used in research 
might be virulent in some circumstances. One of these strains (Y. pestis KIM) caused 
fatal septicemic plague in a researcher who was an insulin-dependent diabetic and 
also had evidence of hereditary hemochromatosis. There is some evidence that 
hemochromatosis might have been a predisposing factor, possibly by providing iron 
deposits this organism was able to exploit. Immunosuppression from the diabetes 
might also have played a role. 
Species Affected 
Rodents and lagomorphs are the most important host species for plague. These 
animals are infested with fleas that can transmit Y. pestis, and develop bacteremia 
high enough to infect those fleas. Infections have been documented in more than 200 
species and subspecies of rodents. Significant rodent hosts include prairie dogs 
(Cynomys spp.), ground squirrels/ susliks (Spermophilus spp.), antelope ground 
squirrels (Ammospermophilus spp.), chipmunks (Tamias spp.), rats (Rattus spp.), 
wood rats (Neotoma spp.). mice (Peromyscus spp.), Siberian marmots (Marmota 
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Meriones spp.). The principal rodent hosts vary with the 
geographic region. Pikas (Ochotona spp.), which are 
lagomorphs, are also important hosts in Asia.  
Many other species of mammals also become 
infected, but the majority are incidental hosts. Some 
species are more likely to develop clinical signs than 
others. Felids seem to be particularly susceptible to 
plague; fatal disease has been reported in housecats and 
wild cats including bobcats (Lynx rufus) and mountain 
lions (Puma concolor). Black-footed ferrets (Mustela 
nigripes) are also very susceptible. Infrequent cases of 
plague have been described in ungulates including camels 
(Camelus bactrianus and Camelus dromedarius), various 
species of deer, pronghorn antelope (Antilocapra 
americana), at least one llama, and goats. Y. pestis 
infections have also been reported in dogs, coyotes (Canis 
latrans), foxes, badgers, skunks and nonhuman primates. 
Zoonotic potential 
Humans are susceptible to infection with Y. pestis as 
incidental hosts, and are not involved in the natural cycle of 
this organism outside epidemics. 
Geographic Distribution 
Y. pestis can be found in parts of Africa, the Middle 
East, Asia, and North and South America, as well as 
Madagascar. The distribution of this organism is patchy. In 
North America, Y. pestis occurs in the western third of the 
continent, from British Columbia and Alberta, Canada to 
Mexico, and as far east as Dallas and the western borders of 
Kansas, Nebraska, Oklahoma and South Dakota. In South 
America, active foci have been identified mainly in Brazil 
and the Andes mountain region of Bolivia, Peru and 
Ecuador. In Asia, plague has been reported from areas in 
the former U.S.S.R. east through China, and south to 
Southwest and Southeast Asia. In Africa, this disease 
occurs primarily in the eastern and southern regions, but 
foci are also found in the west and north. Plague is not 
endemic in Europe or Oceania. 
The distribution of each biovar varies. The Antiqua 
biovar occurs in Africa and Central Asia, and the 
Medievalis biovar seems to be found mainly in Central Asia 
(however, one isolate was reported in northern Africa). The 
Orientalis biovar can be found in most regions where 
plague occurs. 
Transmission 
Plague is usually transmitted by the bites of infected 
fleas. More than 30 species of fleas are capable of 
transmitting Y. pestis, but they vary in their efficiency as 
vectors. The oriental rat flea, Xenopsylla cheopis, is a 
particularly effective biological vector. Other species of 
rodent fleas are also important in transmission. Dog and cat 
fleas (Ctenocephalides spp) can be infected, but are poor 
vectors compared to species such as X. cheopis. Human 
fleas (Pulex irritans) can also carry Y. pestis. Fleas are 
usually short-lived; however, some may survive for several 
months, or even a year or more, in rodent burrows after 
their hosts have died. During epizootics, there is a high risk 
that fleas leaving dead animals will bite species they do not 
usually infest, such as humans. Other arthropods have also 
been proposed as potential vectors. Y. pestis has been 
detected in human lice during outbreaks in people, and lice 
were able to transmit the infection between rabbits in the 
laboratory. Ticks have been suggested as possible 
mechanical vectors in some countries.  
Direct transmission can also occur between animals or 
people, but the importance of this route varies with the form 
of the disease. Y. pestis is present in tissues, draining 
lesions and some body fluids, and these bacteria may enter 
the body through mucous membranes and broken skin. 
Person-to-person spread of bubonic plague seems to be rare 
or nonexistent, though theoretically possible. In contrast, 
people or animals with the pneumonic form may transmit Y. 
pestis in respiratory droplets. In humans, this occurs most 
readily in crowded, poorly ventilated conditions. 
Pnuemonic plague is most contagious during its final 
stages, when the number of bacteria in the sputum 
increases. In the earlier stages, transmission does not seem 
to occur as readily.  
Animals, including cats, can transmit bacteria in bites. 
Carnivores and omnivores, including humans, may also be 
infected by eating tissues from infected animals. In camels 
and other herbivores, this might occur when dead rodents or 
their excretions contaminate the animal’s feed. At present, 
there is little information about the survival and growth of Y. 
pestis in food products. In one study, an attenuated Y. pestis 
strain (Y. pestis KIM5) was able to persist without growth in 
raw meat (ground pork) for at least 2 months at 4°C, and to 
grow in this product at 10-30°C. 
Y. pestis can be transmitted on fomites at least for short 
periods; however, its long-term survival in the environment, 
particularly in soil, is still poorly understood. This organism 
is not resistant to desiccation or heat, and on surfaces such as 
glass and steel, it usually persists for less than 72 hours. 
However, it is reported to survive for long periods of time in 
organic material; it may remain viable for up to 100 days in 
blood and for as long as 9 months in human bodies. Viable Y. 
pestis was recently found after 24 days in soil that had been 
contaminated by the blood of a dead mountain lion. In the 
laboratory, this organism can survive for many months, and 
possibly years, in autoclaved soil, and for long periods in 
water. Rodents have been infected experimentally by 
burrowing in or running over recently contaminated soil, but 
whether this is an important maintenance mechanism for 
plague remains to be determined.  
Epidemiology 
In the wild, Y. pestis seems to be maintained in cycles 
between wild rodents or lagomorphs (e.g., pikas) and 
fleas. Periodically, these animals experience epizootics, 
increasing the risk of transmission to other species. What 
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triggers these epizootics, and how Y. pestis persists during 
interepizootic periods, is poorly understood. Whether this 
organism circulates in its epizootic hosts between 
outbreaks, or in a different ‘maintenance’ host, is 
controversial.  
Sporadic cases of plague occur in people who are 
exposed to tissues from wild animals, or to their fleas. 
Domesticated animals can act as ‘bridges’ that carry Y. 
pestis closer to humans. These animals may become 
infected themselves, or they can simply act as temporary 
hosts for infected fleas. Infection of rodents in urban areas, 
particularly rats, can result in epidemic plague in humans. 
The importance of different transmission routes during 
human epidemics (e.g., aerosols, or transmission via 
ectoparasites) is still incompletely understood.  
Human infections 
Most human cases are associated with wild rodents or 
lagomorphs, but other species have also been involved. 
Among domesticated animals, cats seem to be most likely to 
transmit plague to humans. Unusually, a recent case of 
primary pneumonic plague in China, which then spread to 11 
human contacts, was attributed to close contact with a 
severely ill, Y. pestis (Antiqua biovar) infected dog. One 
study suggested that extended contact with dogs may 
increase the risk of plague, possibly by bringing infected 
rodent fleas into the household. Small outbreaks have also 
been reported in people who ate uncooked tissues from 
infected hosts (e.g., uncooked camel liver or guinea pig 
flesh). A few human cases have been attributed to contact 
with wild animals including bobcats, coyotes, mountain 
lions, foxes and badgers. In these cases, it may sometimes be 
difficult to determine whether the organism was acquired 
directly from an animal or from infected fleas. 
Disinfection 
Y. pestis is susceptible to a number of disinfectants 
including 1% sodium hypochlorite, 70% ethanol, 2% 
glutaraldehyde, formaldehyde, and iodine–based and 
phenolic disinfectants. It can also be inactivated by moist 
heat (121° C [250° F] for at least 15 minutes) or dry heat 
(160-170° C [320-338°F] for at least 1 hour). 
Infections in Animals 
Incubation Period 
Clinical signs usually develop within 1 to 4 days in 
cats. Few cases have been reported in other species. 
Clinical Signs 
The three principal forms of plague - bubonic plague, 
septicemic plague and pneumonic plague - seem to occur in 
animals as well as humans; however, plague should be a 
consideration in any animal with a systemic infection and a 
history of potential exposure in an endemic area. 
Most cats infected with Y. pestis develop the bubonic 
form. This form is usually characterized by fever, anorexia 
and lethargy, with an enlarged lymph node (bubo) near the 
site of inoculation. Many cats are probably infected by 
ingestion, and the submandibular lymph nodes are most 
often involved. The affected lymph node may develop 
abscesses, ulcerate and drain. Some cats also have cellulitis, 
abscesses at sites other than lymph nodes, mouth lesions 
including ulcers, or necrotic tonsillitis. Vomiting, diarrhea, 
ocular discharges, dehydration and weight loss have been 
reported. Bubonic plague can progress to septicemic 
plague, with typical signs of sepsis. Disseminated 
intravascular coagulation (DIC) and/or respiratory distress 
may be seen. Primary septicemic plague, without a bubo, 
has also been reported in cats. Pneumonic plague can 
develop in cats with bubonic or septicemic plague, and is 
characterized by respiratory signs including dyspnea and 
hemoptysis. Neurological signs such as incoordination have 
been reported in some infected cats. Studies in 
experimentally infected cats and serological surveys 
suggest that some animals might have mild or 
asymptomatic infections after exposure.  
Dogs seem less likely to become ill than cats, and 
subclinical infections may be more common. Only rare 
descriptions of plague in naturally infected dogs have been 
published: the clinical signs included fever, lethargy, 
submandibular lymphadenitis, lesions in the mouth and 
coughing. Two recent, linked cases in China were 
characterized by prostration, anorexia, and severe coughing 
and vomiting with blood in the nose and mouth, and death 
within a few days. Experimentally infected dogs inoculated 
by the subcutaneous or oral routes developed a fever and 
other signs of illness, but recovered spontaneously during 
the next week. However, two dogs exposed via aerosols 
died. 
In rodents, the outcome varies from subclinical 
infection or mild illness to severe, rapidly fatal disease. 
Epizootics with high mortality rates are reported among 
some rodents and lagomorphs. Infections in other wild 
animals are poorly understood. Infected mountain lions, 
bobcats, coyotes, foxes and other animals have occasionally 
been found dead. Fever and lethargy, without bacteremia, 
were reported in experimentally infected raccoons in one 
study. In another experiment, neither fever nor deaths were 
seen in this species, or in coyotes and striped skunks 
infected by the oral route. Whether individual susceptibility 
or other factors (e.g., dose or route of exposure, or 
underlying illness) affect the outcome in these species is not 
known. 
Occasional cases of plague have been reported in 
domesticated or wild ungulates. Ocular plague, 
characterized by keratoconjunctivitis, endophthalmitis and 
panophthalmitis, has been documented in mule deer 
(Odocoileus hemionus) and black-tailed deer (Odocoileus 
hemionus columbianus). Septicemia and pneumonia have 
also been seen in mule deer, either with or without ocular 
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signs. Overall, plague is not reported to be an important 
cause of morbidity and mortality in this species. Goats and 
camels can become ill and die, and a death was reported in 
a llama in New Mexico. Clinical cases have not been 
reported in the literature in cattle, horses or pigs.  
Post Mortem Lesions      Click to view images 
In cats, necrotic foci may be found in the liver, spleen, 
lungs and other internal organs. The liver may be pale and 
the spleen enlarged. Affected lymph nodes can be markedly 
swollen, with necrosuppurative inflammation, edema and 
hemorrhages. Diffuse interstitial pneumonia, focal 
congestion, abscesses and hemorrhages may be found in the 
lungs.  
In wild animals, reported lesions have included 
hemorrhagic buboes and splenomegaly in some acute cases, 
or caseous buboes and necrotic lesions in the spleen, liver 
and lungs when the disease progresses more slowly. 
Keratoconjunctivitis, endophthalmitis and panophthalmitis, 
as well as septicemic lesions, pneumonia and lymphadenitis 
have been reported in deer.  
Diagnostic Tests 
A presumptive diagnosis can be made by identifying the 
characteristic organisms in clinical samples such as lymph 
node (bubo) aspirates or swabs of draining lesions. Some 
types of samples, such as lymph nodes, may contain a 
relatively homogenous population of bacteria. Y. pestis is a 
Gram negative, facultative intracellular coccobacillus or 
bacillus with bipolar staining. Bipolar staining is particularly 
evident when Wright-Giemsa or Wayson stains are used. 
Bacteria in clinical samples can be identified by 
immunofluorescence. Rapid immunoassays can also be used 
to detect Y. pestis antigens in clinical samples, and PCR may 
be used to identify nucleic acids. Y. pestis can sometimes be 
detected by PCR or other techniques in fleas collected from 
the animal.  
Plague can also be diagnosed by isolating Y. pestis from 
blood, nasal/oral swabs, lymph node aspirates, swabs of 
draining lesions, transtracheal aspirates and/or tissue samples 
including the liver, spleen, lungs and affected lymph nodes. 
Specimens for culture should be collected before antibiotics 
are started. Y. pestis will grow on ordinary media including 
blood agar, MacConkey agar, nutrient agar or brain-heart 
infusion broth. Yersinia-specific CIN agar can also be used; 
this medium is particularly helpful with contaminated 
samples. Y. pestis can be identified with routine biochemical 
tests and other methods. It should be kept in mind that 
automated systems may misidentify this bacterium, as it 
grows slowly and biochemical reactions may be delayed. A 
specific bacteriophage that lyses only Y. pestis and not Y. 
pseudotuberculosis is used as a rapid diagnostic test in 
reference laboratories. Although animal assays are generally 
discouraged if there are other alternatives, Y. pestis may also 
be recovered in laboratory animals such as mice, particularly 
when the sample is contaminated with other organisms. 
Serology using paired serum samples can be helpful. A 
single sample, together with consistent clinical signs, may 
also be supportive. Various serological tests including latex 
hemagglutination and passive hemagglutination may be 
available. 
Treatment 
Early treatment with antibiotics can be successful. 
Some antibiotics that have been used to treat plague in 
animals include streptomycin, gentamicin, doxycycline, 
tetracycline and chloramphenicol. Drug availability may 
vary with the country. 
Control 
Disease reporting 
Veterinarians who encounter or suspect a case of 
plague should follow their national and/or local guidelines 
for disease reporting. In endemic areas, prompt reporting 
helps prevent exposure of other animals and humans. In 
addition to any other state reporting requirements, all 
suspected cases of animal or human plague in the U.S. 
should be reported to the local or state public health 
department. The state public health laboratory or U.S. 
Centers for Disease Control (CDC) laboratory should be 
contacted before collecting or shipping samples.  
Prevention  
A good flea control program should be established for 
dogs and cats, and they should be kept from eating tissues 
from animals that may be infected. Allowing animals to 
hunt or roam increases the risk of infection in endemic 
areas. Animals that become ill should be examined by a 
veterinarian. Barrier precautions are necessary during 
examination and treatment, and suspected cases are 
isolated. The most stringent measures are needed before 
antibiotics are begun and during the initial stages of 
treatment. Personal protective equipment (PPE) may 
include gloves, surgical masks to prevent droplet infection, 
protective clothing, and eye protection if splashes or sprays 
are expected. Excellent hygiene should be practiced.  
Vaccination has been used to protect endangered black-
footed ferrets, which are highly susceptible to plague, 
during epizootics. Vaccines (in food bait) were also given 
to prairie dogs, which are the food source for these ferrets, 
and prairie dog burrows were dusted with an insecticide. 
Vaccines have been tested in other wildlife species 
susceptible to plague, and they might be promising for 
controlling Y. pestis in rodents near human environments. 
Vaccines are not currently available for domesticated 
animals. 
Morbidity and Mortality 
In endemic areas, epizootics occur periodically in 
susceptible rodents and lagomorphs. Resistance to plague 
differs between rodent species, and the percentage of 
individuals that survive Y. pestis infection can vary. The 
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mortality rate in some species can approach 100%. Between 
epizootics, plague persists in wild animals without causing 
high mortality. Populations that live in endemic areas may 
be more resistant than those outside these regions.  
Among domesticated animals, cats seem to be 
particularly susceptible to plague. One study reported that the 
mortality rate was 14% in housecats with bubonic plague, 
70% in cats with septicemic plague (or cases that were not 
classified into a form), and 83% in the pneumonic form. In 
experimentally infected cats with bubonic plague, the case 
fatality rate can be as high as 60% if the disease is left 
untreated. Subclinical infections also seem to occur. 
Surveillance has reported antibodies in healthy cats, and 
some cats have survived experimental infections. In one 
study, 20 of 25 cats inoculated by ingestion or subcutaneous 
inoculation became ill, but three cats seroconverted without 
clinical signs. Dogs do not seem to be as susceptible to 
plague as cats. Ten experimentally infected dogs that were 
inoculated by subcutaneous or oral inoculation experienced 
only a brief illness and recovered on their own. However, 
severe illness is possible. Two dogs infected by aerosols died, 
and fatal cases of plague have been reported rarely in 
naturally infected dogs. 
Serological evidence suggests that wild carnivores are 
frequently exposed to Y. pestis, probably through hunting. 
Fatal cases of plague have been reported in large cats 
including bobcats and mountain lions. A recent survey from 
the western U.S. found that 2% of apparently healthy 
bobcats and mountain lions in California, and 21% to 46% 
of these animals in different regions of Colorado, had 
antibodies to Y. pestis. Seroprevalence rates of 13-14% in 
raccoons and coyotes, and 55% in badgers, have also been 
reported. Endangered black-footed ferrets (M. nigripes) are 
very susceptible to plague, and have a high mortality rate. 
In contrast, experimentally infected domesticated ferrets 
(Mustela putorius furo) and Siberian polecats (M. 
eversmanni) did not become ill.  
Infections in Humans 
Incubation Period 
Pneumonic plague develops rapidly, within 1 to 4 days. 
The incubation period for bubonic plague is 1 to 10 days, but 
in most cases, the symptoms usually appear in 2 to 5 days. 
Clinical Signs 
Bubonic plague is the most common form of plague in 
humans. It begins with the sudden onset of high fever, chills, 
headache, malaise and myalgia. Dizziness, nausea and 
vomiting may also be seen, in addition to an infected, 
swollen and very painful draining lymph node (the bubo). 
Although it can occur anywhere, the bubo is often one of the 
femoral or inguinal lymph nodes. In some cases, a pustule, 
vesicle, eschar or papule may be found at the site of the flea 
bite; however, this is often absent or missed. People who 
become infected by ingestion can develop severe pharyngitis 
and tonsillitis, with swelling of a submandibular lymph node 
and the neck. Vomiting, diarrhea and abdominal pain may 
also be seen. In a recent outbreak linked to eating 
undercooked camel meat, gastrointestinal signs without 
prominent pharyngeal signs were the primary syndrome. If it 
is not treated, bubonic plague often progresses to septicemia 
and/or secondary pneumonia. 
Approximately 10-25% of human plague cases are 
characterized by primary septicemia. In addition to high 
fever and other signs in common with bubonic plague, this 
form has signs of sepsis, but there may be no obvious 
involvement of the lymph nodes. Epistaxis, hematuria 
petechiae, DIC and neurological signs may also be seen, 
and the course of the disease can be rapid, with multiorgan 
failure. Secondary septicemia is similar, but results from 
disseminated bubonic plague. Meningitis is a relatively rare 
form of plague; it occurs in approximately 6% of people 
with the septicemic or pneumonic forms.  
Pneumonic plague occurs after the inhalation of 
bacteria or after blood–borne spread to the lungs. The 
symptoms of pneumonic plague develop acutely and 
include high fever, chills, headache (often severe), myalgia, 
malaise and an increased respiratory rate. Within 24 hours, 
a cough develops; it is initially dry but becomes productive, 
then bloodstained and/or purulent. The sputum contains 
only specks of blood at first but eventually becomes foamy 
and pink or red from blood. Pneumonic plague is rapidly 
fatal, with dyspnea, stridor and cyanosis ending in 
respiratory failure and circulatory collapse. 
Pestis minor is a benign form of bubonic plague, 
usually seen only among people in regions where plague is 
common. Pestis minor is characterized by fever, 
lymphadenitis, headache and prostration, which resolve 
spontaneously within a week. 
Diagnostic Tests 
A presumptive diagnosis can be made, as for animals, 
by identifying the characteristic organisms in sputum, 
bronchial/tracheal washings, blood, lymph node (bubo) 
aspirates, cerebrospinal fluid (CSF) or postmortem tissue 
samples. Rapid immunoassays employed with human 
samples include an F1 antigen test used in Africa. 
Plague can also be diagnosed by isolating Y. pestis. 
Organisms may be recovered from respiratory secretions, 
blood and/or aspirates of affected lymph nodes, depending 
on the form of the disease, as well as from lungs and other 
tissues postmortem. Organisms are usually present in blood 
only during septicemia; however, bacteria are sometimes 
released intermittently from lymph nodes into the blood, 
and a series of blood samples collected 10-30 minutes apart 
may be diagnostic. Specimens for culture should be 
collected before antibiotics are started.  
Serology is occasionally helpful. Serological tests 
include ELISAs, passive hemagglutination, 
hemagglutination-inhibition, latex agglutination and 
complement fixation. A fourfold rise in titer is diagnostic.  
Plague 
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Treatment 
Antibiotics are effective for the treatment of plague; 
however, their efficacy in the pneumonic form is often 
limited if the symptoms have been present for more than 20 
hours. Buboes are occasionally drained but usually resolve 
with antibiotic treatment. Although antibiotic resistant 
strains of Y. pestis have been detected, they seem to be rare. 
In a recent study, no resistant Y. pestis was found among 
approximately 400 isolates from the Americas, Asia and 
Africa, including nearly 300 organisms isolated between 
1995 and 2009. 
Control 
In endemic areas, rodents should be controlled around 
human homes, workplaces and recreational areas. 
Buildings should be rodent-proofed, and access to food 
sources should be prevented. Brush, rock piles, junk and 
cluttered firewood should not be allowed to accumulate, 
as they may provide nesting places for rodents. Campers 
and hikers should not approach rodents or their carcasses, 
and should avoid sleeping beside rodent burrows. 
Prevention methods for pets (see Animal section) can help 
keep them from becoming infected or carrying infected 
fleas into the home. Game meat, as well as tissues from 
domesticated animals that might be infected, should be 
cooked thoroughly if they are eaten (however, eating 
tissues from sick animals is not recommended). Die-offs 
of rodents or lagomorphs should be reported.  
Personal protective equipment (PPE) should be worn 
when handling animals if there is any risk that they might 
be infected. More stringent precautions are necessary when 
pneumonic plague is suspected or higher risk procedures 
such as necropsies are performed. Good hygiene, including 
frequent hand washing, should be practiced. Insect 
repellents can also be applied to clothing and skin if 
exposure to rodent fleas is expected. Specific 
recommendations for protective measures are available 
from the CDC and other groups (see Internet Resources, 
below). 
In endemic regions, rodents that host Y. pestis may be 
monitored and/or controlled. Concurrent insecticidal 
treatment is often necessary when hosts die or are killed, as 
fleas leave the carcasses to seek new hosts. People who 
have been exposed to Y. pestis are treated prophylactically 
with antibiotics. Good infection control procedures, 
including the use of disposable surgical masks, are used to 
prevent transmission from patients with pneumonic plague.  
Human vaccines may be used in some countries or high 
risk groups, but there are concerns about their safety and 
efficacy, and their availability is limited. Efforts to create 
safe and effective human vaccines, as well as vaccine baits 
to reduce environmental load, are areas of current research.   
Morbidity and Mortality 
Y. pestis is endemic in populations of wild rodents and 
lagomorphs, and occasionally spills over to affect people or 
other animals. Worldwide, approximately 1,000 to 2,000 
human cases of plague and 100 to 200 deaths are currently 
reported annually to the World Health Organization 
(decreased from a high of 5,000 cases in 1997). The exact 
number of plague cases is, however, uncertain. Some 
reported cases are not laboratory confirmed, and 
conversely, many cases are probably not diagnosed. Most 
outbreaks occur in Asia and Africa, but sporadic cases and 
outbreaks can be seen in any endemic region. On average, 
fewer than 20 cases of plague are reported annually in the 
U.S., but up to 40 cases have been reported in some years. 
Plague may reoccur after a long period when the disease 
seems to disappear; recent outbreaks in India, Indonesia and 
Zambia followed quiescent periods of 30 to 50 years.   
Bubonic plague accounts for 80–95% of the cases seen 
worldwide. Without treatment, the case fatality rate for this 
form is estimated to be 40-70%; some sources suggest it 
may be as high as 90%. The availability of treatment lowers 
the case fatality rate in bubonic or septicemic plague to 
approximately 5–15%. Untreated pneumonic or septicemic 
plague is almost always fatal, often within a few days. If 
appropriate treatment is given very soon after the onset of 
symptoms, most people survive; however, the narrow 
window for treatment means that the case fatality rate for 
the pneumonic form remains greater than 50%. 
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